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Influenza C is not included in the annual seasonal influenza vaccine, and has historically been regarded 
as a minor respiratory pathogen. However, recent work has highlighted its potential role as a cause 
of pneumonia in infants. We performed nasopharyngeal or nasal swabbing and/or serum sampling 
(n = 148) in Lancaster, UK, over the winter of 2014–2015. Using enzyme-linked immunosorbent assay 
(ELISA), we obtain seropositivity of 77%. By contrast, only 2 individuals, both asymptomatic adults, 
were influenza C-positive by polymerase chain reaction (PCR). Deep sequencing of nasopharyngeal 
samples produced partial sequences for 4 genome segments in one of these patients. Bayesian 
phylogenetic analysis demonstrated that the influenza C genome from this individual is evolutionarily 
distant to those sampled in recent years and represents a novel genome constellation, indicating that 
it may be a product of a decades-old reassortment event. Although we find no evidence that influenza 
C was a significant respiratory pathogen during the winter of 2014–2015 in Lancaster, we confirm 
previous observations of seropositivity in the majority of the population. (170 words).
Clinical presentation. Influenza C (family Orthomyxoviridae, genus Influenzavirus C, species Influenza C 
virus) produces malaise, coryza and fever when administered to susceptible adult volunteers1. Historically, influ-
enza C has been regarded as the least serious of the three species of influenza infecting humans, and seasonal 
vaccination programmes have been confined to influenzas A and B. More recent studies confirmed influenza C’s 
production of a mild respiratory illness in healthy adults, with only occasional complications2.
However, in a paediatric context, acute respiratory illness and/or pneumonia have been reported as a con-
sequence of influenza C infection3–8 especially in those under 2 years old9, as well as vomiting, diarrhoea, acute 
otitis media10, a high rate of hospitalization11 and even acute encephalopathy12. This growing awareness of the 
paediatric clinical importance of influenza C raises the issue of its inclusion in the annual seasonal influenza 
vaccine, or its position as a candidate for vaccine development specifically for infants.
Epidemiology. Nearly 40% of adult volunteers were susceptible to administered influenza C1. The 60% who 
did not develop disease is consonant with observation of seropositivity levels of 59% in Spain13, 61% in France14 
and 57% in Brazil15, and suggests that seropositivity may possibly confer resistance. By contrast, other studies 
have suggested that antibodies against influenza C tend to be more universal: 100% in an isolated Philippine 
village16 and in the USA17, 90% in Czechoslovakia18, 86% in the Soviet Union18 and 70% in East Germany19. Some 
studies have also found age-structured variability: in California, seropositivity of 64% in children under 5 but 98% 
in adults20; in Japan, 40–50% in early childhood to nearly 100% in adulthood21; in Louisiana, 47% in children to 
96% in younger adults, but then a decline to 18% in the over-65s22; in France, 46% seropositivity in children, 76% 
in younger adults, but only 44% in the over-50s14.
Influenza C does not appear to be seasonal, based on contemporaneous two-year surveys of its occurrence in 
Bucharest and Japan from 1988–19906,23. Using this observation together with the seropositivity data, it is possible 
to propose several epidemiological scenarios. The first of these is that influenza C is an endemic virus in human 
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populations, with approximately lifelong immunity conferred by first exposure. The decline in seropositivity in 
later life14,22, potentially due to immunosenescence, would then provide the virus with opportunities to infect 
individuals for a second time. The second scenario is that the virus is only intermittently epidemic, with variation 
in seropositivity a reflection of previous epidemic history in different locations. The third scenario is that the virus 
is endemic but antigenically variable over time24. Seropositivity would therefore be an unreliable guide to the true 
immune status of any individual.
Phylogenetics and molecular evolution. The rate of nucleotide substitution is lower in influenza C than 
in A and B25–28, and reassortment has been detected3,6,25,28–30. There is also evidence of positive selection at two 
residues in the receptor-binding domain of the haemagglutinin-esterase (HE) protein, but the overall ratio of 
non-synonymous to synonymous substitutions (omega) across the genome is low, individual proteins ranging 
from 0.05 to 0.1328. The low levels of omega indicate a virus that is well adapted to its host, but the presence of 
positive selection in the HE receptor-binding domain also indicates selective pressure from the host immune 
system. This provides a molecular explanation for the observed antigenic drift24 and some evidence against the 
scenario that humans are likely to acquire lifelong immunity.
The issue of endemicity versus sporadic epidemics also remains unresolved. Only one candidate epidemic 
surge has been identified, in Japan in 20044. The existence of reassorted strains indicates that double infection 
with two or more strains cannot be very infrequent, implying that it ought to be possible to detect numerous (or 
at least > 1) strains co-circulating both temporally and geographically, previously demonstrated in Japan4. Indeed, 
a continually shifting pattern of segment combinations, referred to as genome constellations28, is observed when 
full genomes are studied, a phenomenon also seen in influenza B31. Eight genome constellations circulating in the 
1990s differed from the genome constellations present in a set of reference genomes from the 1940s to the 1980s28.
Results
Participants. Of the 148 participants, 69 were male and 79 female. 71 were symptomatic and 77 asympto-
matic. Distribution of male and female participants within symptomatic and asymptomatic groups was assessed 
by a 2 × 2 chi-square test and was not statistically significant. Except for a relative excess of age group 20–29 par-
ticipants (mostly from the university), age approximated a normal distribution.
Influenza C seropositivity. Of the 148 participants, 129 consented to donate serum. Of these 99 were sero-
positive and 30 negative, giving a figure of 77% seropositivity. Figure 1 shows the anti-influenza C IgG concen-
tration by age. Gender differences in seropositivity were also nearly absent (male mean 2.5 mg/dl, female mean 
2.3 mg/dl) with no statistical significance on t-test, but symptomatic individuals had slightly more IgG (sympto-
matic mean 2.6 mg/dl, asymptomatic mean 2.2 mg/dl), significant on a t-test at p < 0.05. A Mann Whitney U-test 
was performed on the distribution of seropositive individuals between each age group, and was not statistically 
significant.
Detection of viral RNA. Two participants out of 148 (1.4%), aged 51 years and 70 years, both asymptomatic, 
were detected as positive for influenza C using quantitative PCR, at 135 ng and 160 ng total viral RNA respectively, 
corresponding to 1.9 × 1010 and 2.2 × 1010 genome copies. Since influenza viruses are believed to have a single 
genome copy per virion32, this indicates approximately 2 × 1010 virions per individual nasopharyngeal swab. On 
deep sequencing (accessions SRR4733498 and SRR4733494), only one patient showed sufficient levels of influ-
enza C reads for genome assembly to be attempted (SRR4733498).
Genetic relationships of isolated influenza C genome segments. Partial genome segment sequences 
were obtained from deep sequencing for segments 1, 5, 6 and 7, encoding PB2, NP, M1/CM2 and NS1/NS2 
respectively. Those greater than 200 bases are deposited in GenBank, accession numbers KY075640 - KY075642. 
Insufficient reads were available to assemble the other segments. Although breadth of coverage across segments 
is low (ranging from 22% in segment 5 to 32% in segment 6), there is sufficient genetic information to assign 
each fragment to a clade as defined previously28, using Bayesian phylogenetics. Plotting of the root-to-tip genetic 
distance on a neighbour-joining tree using TempEst showed that molecular clocks apply best to segments 2 and 
7 (PB2 and NS1/NS2), but that both segments 5 and 6 (NP and M1/CM2) have lower root-to-tip distances for 
Figure 1. Anti-influenza C IgG concentration (mg/dl), plotted for each individual against age. Blue: > 
2 standard deviations above negative control; green: 1–2 standard deviations above negative control; red: < 1 
standard deviation above negative control.
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C/Lancaster/1/2015 than expected. Figures 2 and 3 shows the TempEst plots for segments 1 and 6 (PB2 and M1/
CM2), giving examples of clock-like and non-clock-like behaviour, respectively. The TempEst plots for segments 5 
and 7 (NP and NS1/NS2) are Supplementary Figures 3 and 4 respectively. The new strain of influenza C identified 
was designated C/Lancaster/1/2015.
Clade memberships were determined by examination of Bayesian phylogenetic trees produced in BEAST, 
as previously28 and then annotated onto the neighbour-joining trees used for the molecular clock analysis. 
Figure 4 shows the tree for segment 5 (encoding NP), demonstrating that C/Lancaster/1/2015 belongs to the C/
Miyagi/1/93 clade, and not to the C/Greece/79 and C/pig/Beijing/81 clades circulating in recent isolates. Figure 5 
shows the tree for segment 7 (encoding NS1/NS2) has an even more distant relationship to recent genomes, 
being part of the C/Sapporo/71 clade last seen in 1979. The phylogenetic trees for PB2 and MP are given in 
Supplementary Figures 1 and 2, and further confirm the genetic distance between C/Lancaster/1/2015 and other 
recently sequenced genomes. Clade memberships are then synthesised to derive the relationship between C/
Lancaster/1/2015 and defined genome constellations (Table 1).
Discussion
Our participant group were 77% seropositive to influenza C. This is slightly higher than the 57–61% levels 
from studies in western Europe and Brazil13–15, within the range of the 70–90% found in eastern Europe18,19 
but still considerably short of those studies reporting universal seropositivity in the USA and east Asia16,17. As 
in previous studies, our antibody titre levels were widely variable among those classed as seropositive, and our 
choice of threshold is purely statistical. However, we also found no statistically significant age-structured or 
gender-structured variability in seropositivity (Fig. 1). This is at variance with some previous studies in the USA, 
Japan and Europe14,20–22. It should also be noted that many serological studies on influenza C are now some dec-
ades old and techniques have varied over the years, so individual studies are not necessarily directly comparable. 
We also cannot exclude the possibility of some cross-reactivity of our influenza C antigen with antibodies to other 
influenza viruses, but this is also an issue in all previous studies.
Neither of the two participants who were identified as influenza C-positive by PCR generated sufficient deep 
sequencing reads for complete genomes to be assembled. Our deep sequencing of the nasopharyngeal swabs of 
both of our PCR-positive participants, produced much fuller genome sequence results for other RNA viruses 
Figure 2. Root-to-tip distance in a neighbour joining tree for segment 1 (encoding PB2) of the influenza C 
genome. 100 full-length or near full-length genome segments (2365 bases) are used plus the 724 discontinuous 
bases of segment 1 derived from deep sequencing. C/Lancaster/1/2015 has a degree of divergence from the root 
consistent with molecular clock-like behaviour in its lineage.
Figure 3. Root-to-tip distance in a neighbour joining tree for segment 6 (encoding M1/CM2) segment of 
the influenza C genome. 86 full-length or near full-length genome segments (1180 bases) are used plus the 380 
discontinuous bases of segment 6 derived from deep sequencing. C/Lancaster/1/2015 is less divergent from the 
root than it should be given its known sampling date, consistent with a perturbation of molecular clock-like 
behaviour in its lineage.
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apart from influenza C, as well as sequences from a range of bacterial species (Atkinson et al. in preparation). We 
therefore do not think that the difficulty in detecting influenza C, or in generating complete genomes, is due to 
RNA degradation or other technical failure. The 4 segments partially assembled are the least variable segments, 
but only segment 4, encoding HE, is an outlier in terms of its variability, at 0.042 substitutions per site since 1947, 
compared to a range of 0.017 to 0.027 for the other segments28. Even within HE there are relatively conserved 
regions within the stalk domain, so we do not believe that failure to assemble HE or other segments is an artefact 
of excessive stringency in our assembly process.
In the individual with the 4 partial genome segment sequences, it is evident that C/Lancaster/1/2015 is a reas-
sortant that does not fall into any of the genome constellations previously classified28 (see also Table 1). It contains 
a rare NS1/NS2 segment of the C/Sapporo/71 clade, related to sequences that were last observed in the late 1970s. 
Influenza C genomes sequenced since 2010 all have the C/Shizuoka/79 clade in the NS1/NS2 segment (Fig. 5). 
C/Lancaster/1/2015 also has a rare NP segment of the C/Miyagi/1/93 clade, related to sequences that were last 
observed around 2000 (Fig. 4) and typical of genome constellation 4a (Table 1). The other segments are within 
clades found more recently, although C/Lancaster/1/2015’s position within these clades is never close to any of 
the recent genome sequences (Supplementary Figures 1 and 2). The exact position of C/Lancaster/1/2015 on each 
segment’s phylogenetic tree is rarely well supported by Bayesian phylogenetics posterior probability density, but 
its location within each of the broader clades is well supported. We therefore conclude that its apparent reassor-
tant nature is unlikely to be simply an artefact of partial sequence information.
Tentative reconstruction of the reassortment event may be attempted. Previous work28 defines genome con-
stellation 4a as consisting of C/Sapporo/71, C/Miyagi/1/93, C/Sapporo/71 and C/Shizuoka/79 in segments 1, 
5, 6 and 7 respectively. The corresponding clades for C/Lancaster/1/2015 are C/Sapporo/71, C/Miyagi/1/93, C/
Sapporo/71 and C/Sapporo/71 respectively (Table 1), suggesting that a strain of constellation 4a reassorted with 
one containing a C/Sapporo/71-clade segment 7. Since no strain containing a segment 7 of this clade has been 
seen since the 1970s and constellation 4a was only seen in the 1990s, it seems likely that the reassortment event 
occurred in the 1990s. This would also explain the dissimilarity of C/Lancaster/1/2015 in all of its segments, to 
other recently sequenced strains. We are tempted to speculate that this reassortant occurred locally in Lancaster, 
but in the absence of any other British genomes since C/England/892/198333, which is itself incomplete, it is 
impossible to come a conclusion.
If this scenario is common in small isolated populations, influenza C diversity in terms of shifting genome 
constellations may be even greater than suggested from the available genomes. The M1/CM2 (Fig. 3) and NP 
segments (Supplementary Figure 3) for C/Lancaster/1/2015 have lower root-to-tip distances than expected 
under the assumption of molecular clock-like evolution. When this method is used on database-derived 
sequences, it is often taken as indicative of incorrect dating. However, given that we know precisely when our 
Figure 4. Neighbour joining tree rooted on C/Taylor/1233/1947 for segment 5 (NP), annotated with clades 
as previously derived28, demonstrating the closer relationship of C/Lancaster/1/2015 (red) to NP segments 
of the C/Miyagi/1/93 clade than to recent isolates. Scale: substitutions per site.
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samples were collected, it is more likely to reflect a genuinely slower rate of evolution in these samples. The 
M1/CM2 segment of C/Lancaster/1/2015 is positioned in the phylogenetic tree near segments from the 1980s 
(Supplementary Figure 1) and the NP segment near segments from the 1990s and 2000 (Fig. 4). This same phe-
nomenon of slowed molecular clock, and aberrant positioning with the phylogenetic tree, has been seen in some 
strains of Zaire ebolavirus34 and also in the 1977 “Russian Flu” H1N1 outbreak35, and is thought be a consequence 
of the virus entering a host population where the serial interval – the time between infection of one host and the 
next in a transmission chain – is reduced and the virus therefore spends longer in a non-replicative state. For 
ebolavirus, this is assumed to be a non-typical animal reservoir host, and for Russian Flu possibly a laboratory 
freezer. Neither of these options would seem to be possible for influenza C, so it may simply be a cumulative result 
Figure 5. Neighbour joining tree rooted on C/Taylor/1233/1947 for segment 7 (NS1/NS2), annotated with 
clades as previously derived28, demonstrating the closer relationship of C/Lancaster/1/2015 (red) to NS1/
NS2 segments of the C/Sapporo/71 clade from the 1970s than to recent isolates. Scale: substitutions per site.
Genome segment 
(encoded protein)
Clade of segment in Lancaster 
consensus, as defined by Gatherer28
Genome constellation in 
which that clade is present Clade(s) of other post 2009 genomes
1 (PB2) C/Sapporo/71 All, except 5 C/Greece/79; C/Sapporo/71
5 (NP) C/Miyagi/1/93 4a C/pig/115/Beijing/81; C/Greece/79
6 (M1/CM2) C/Sapporo/71 All, except 2 & 3 C/Sapporo/71
7 (NS1/NS2) C/Sapporo/71 None: clade not seen since 1970s C/Shizuoka/79
Table 1.  Clade membership of segments of C/Lancaster/1/2015 and the prior clade and genome 
constellation classifications as previously derived28. The rightmost column lists those clades found in other 
segments sequenced from 2010 onwards. Segments 1 and 6 of C/Lancaster/1/2015 are outliers within clades 
found in other recent genomes, but segments 5 and 7 are not.
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of low transmission rates within relatively small populations slightly delaying the average serial interval, condi-
tions which could apply in Lancaster.
We began this study with the premise that influenza C might be a candidate for inclusion in the seasonal influ-
enza vaccine. Our results do not provide any support for the proposition that vaccination of adults is appropriate, 
consistent with the conclusion of one other recent report36. Although we recruited 71 symptomatic individuals 
with a range of cold/flu-like symptoms, none of these was influenza C-positive, and none of the respiratory dis-
ease burden in Lancaster during our study period can be attributed to influenza C.
There may still be a case for vaccination of children in the light of published reports of serious respiratory dis-
ease caused by influenza C in that age group3–12,37. We recruited 6 participants in the < 9 years age group but none 
were consented to allow serum sampling. In the single participant in the 10-19 year age group, anti-influenza C 
IgG levels were at < 1 mg/dl and this individual is classified as seronegative (Fig. 1). Haemagglutinin-inhibition 
assay (HI) would potentially clarify this issue, but in its absence we can only draw limited conclusions at best 
concerning the clinical implications of seropositivity, as quantified by ELISA.
Methods
Ethics. Ethical approval was granted by the UK National Research Ethics Service (NRES), reference 14/
LO/1634, Integrated Research Application System (IRAS) Project 147631. The project was registered with the 
National Institute of Health Research (NIHR), UK as part of the NIHR Clinical Research Network (UKCRN) 
Portfolio, ID 17799. All methods were carried out in accordance with the relevant guidelines and regulations. 
Informed consent was obtained from all volunteers of 18 years and older. For those under 18 years, informed 
parental consent was obtained, together with supervised assent of the volunteer.
Patient recruitment. Lancaster (54.05°N 2.80°W) is a small city with a population of 45,000 (141,000 
including surrounding towns and villages). The permanent resident population is > 95% white and 18% are over 
age 65. Participants were approached in 3 locations from November 2014 to May 2015: 1) Lancaster University, 
2) a general practice (GP), 3) hospital clinics. After informed consent was given, patients with coryza and/or 
other symptoms consistent with respiratory infection, were classified as the symptomatic group (n = 71) and the 
remainder as asymptomatic (n = 77). The latter were included to investigate if influenza C could be detected in 
patients without coryza. Nasopharyngeal (or nasal) swabbing, blood sampling, or both, were performed on the 
patients, according to consent.
Sample processing. Nasopharyngeal swabs (MW951SENT, Medical Wire) were used on the rear wall of 
the nasopharynx or nose (according to consent) of patients, and the tips then snapped off directly into Sigma 
Virocult® medium.
Blood was drawn or taken from a finger prick, according to consent, using Beckton Dickinson Serum 
Separator® tubes (SST™ ). Serum was separated at 1000–2000 g for 10 minutes (for arm samples) or at 6000–
15000 g for 90 s (for finger-prick samples) and then stored at − 80 °C.
RNA was extracted from the nasopharyngeal swabs using a MagMAX™ Viral RNA Isolation Kit 
(Ambion). The quality and quantity of RNA extracted from samples was assessed by spectrophotometry using 
the NanoDrop® 1000 Spectrophotometer V3.3.0 (Thermo Fisher Scientific). cDNA was prepared using a 
High-Capacity RNA-to-cDNA™ Kit (Applied Biosystems® , Life Technologies™ ) and a Veriti® Thermal Cycler 
(Applied Biosystems® , Life Technologies™ ). The samples were incubated at 37 °C for 60 minutes, before stopping 
the reaction at 95 °C for 5 minutes and then holding at 4 °C. Once completed, the plates were stored at − 20 °C.
Polymerase chain reaction (PCR) was then performed using a 7500 FAST Real-Time PCR system (Applied 
Biosystems® , Life Technologies™ ) with thermo-cycling carried out as follows: one cycle of 95 °C for 10 min and 
45 cycles of 95 °C for 15 s and 60 °C for 1 min. PCR primers for influenza C were as used previously38, and quanti-
fication was performed by reference to a positive control sample at 32 ng/μ l. Concentrations were converted into 
genome copy numbers using http://scienceprimer.com/nucleotide-molecular-weight-calculator. Samples judged 
positive after quantitative PCR were processed using the Illumina Nextera XT library kit and deep sequenced in 
2 × 126 bp format using an Illumina HiSeq2500 system.
Enzyme-linked immunosorbent assay (ELISA) was performed on the serum samples using influenza C anti-
gen as previously described, and using the same antigen preparation38, with goat anti-human HRP-conjugated 
secondary antibody (ab6858, Abcam® ) and SureBlue™ TMB Microwell Peroxidase Substrate solution. 
Absorbance was measured at 450 nM using a Wallac Victor2™ (Perkin Elmer) plate reader. Anti-influenza C IgG 
was quantified by calibration of the peroxidase reaction against a standard dilution series of IgG concentrations. 
The threshold for seropositivity was placed at 2 standard deviations above the mean level of the negative control 
serum.
Genome segment sequence assembly. Illumina reads were trimmed of adapters and other non-genomic 
elements using CutAdapt 1.139 (https://pypi.python.org/pypi/cutadapt), fastq-mcf 0.11.340 (https://expression-
analysis.github.io/ea-utils), and trim_galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/), 
within the Read_cleaner pipeline (Gatherer, unpublished). Ethical approval required that no genetic material 
remain within the samples which could enable identification of patients. Therefore, human genome and tran-
scriptome sequences were removed by iterative alignment onto the NCBI, Ensembl and UCSC human iGenomes 
(http://support.illumina.com/sequencing/sequencing_software/igenome.html), first using bowtie 1.1.141 (http://
bowtie-bio.sourceforge.net/index.shtml), then BWA 0.7.12-r103942 (http://bio-bwa.sourceforge.net) within the 
Valet pipeline (Gatherer, unpublished). Following each alignment, extraction of unaligned reads was achieved 
using samtools 0.1.1943 (http://samtools.sourceforge.net) and the next alignment commenced. Bowtie, BWA 
and samtools were co-ordinated using the Vanator pipeline44 (https://sourceforge.net/projects/vanator-cvr). The 
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resulting trimmed and cleaned reads are available from the Sequence Read Archive (https://www.ncbi.nlm.nih.
gov/sra/: BioSamples SAMN05954290 and SAMN05954291, Runs SRR4733498 and SRR4733494).
Influenza C genome C/Victoria/2/2012 (Genbank ref. KM504282) was selected as a representative of recently 
circulating influenza C and alignment of cleaned reads carried out using bowtie within the Valet pipeline. 
Consensus sequences were constructed using samtools 0.1.19 (bcftools and vcfutils functions). C/Victoria/2/2012 
was used to fill gaps in the consensi and the bowtie alignment repeated. This cycle was performed until a sta-
ble consensus was obtained for each genome segment. The same process was repeated using BWA and com-
bined consensi obtained. Alignment of reads to the final consensi was examined with Tablet45 (https://ics.hutton.
ac.uk/tablet). Resulting assemblies of more than 200 bases were submitted to GenBank (references KY075640 
- KY075642). The new strain of influenza C identified was designated C/Lancaster/1/2015.
Phylogenetics and genome constellations. Sequence alignments of composite partial segments with 
full influenza C genomes from GenBank, were performed using Muscle46 in MEGA47 (http://www.megasoftware.
net) and neighbour joining trees48 constructed. Clock-like behaviour in sequence evolution on those trees was 
checked using TempEst49 (http://tree.bio.ed.ac.uk/software/tempest). Bayesian phylogenetic analysis was per-
formed in BEAST v.1.8.350 (http://tree.bio.ed.ac.uk/software/beast/). A Tamura 3-parameter (T93 + G) substitu-
tion model51, coalescent constant size tree prior and relaxed lognormal clock were run for 100 million iterations 
in BEAST, with a burn-in of 25%. Genome constellations were determined by establishing the clade, as previously 
defined28, in which each genome segment was located.
Data Availability. Statistical analyses on volunteers and ELISAs, BAM files and reference genomes for 
genome assemblies, genome fragments too short for inclusion in GenBank, BEAST inputs and outputs, TempEst 
inputs and outputs and pipeline Perl scripts, are available from: doi://10.17635/lancaster/researchdata/111.
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Erratum: Influenza C in Lancaster, 
UK, in the winter of 2014–2015
Kate V. Atkinson, Lisa A. Bishop, Glenn Rhodes, Nicolas Salez, Neil R. McEwan, 
Matthew J. Hegarty, Julie Robey, Nicola Harding, Simon Wetherell, Robert M. Lauder, 
Roger W. Pickup, Mark Wilkinson & Derek Gatherer
Scientific Reports 7:46578; doi: 10.1038/srep46578; published online 13 April 2017; updated on 26 May 2017
The original version of this Article incorrectly included the following text in the Methods section:
“Statistical analyses on volunteers and ELISAs, BAM files and reference genomes for genome assemblies, genome 
fragments too short for inclusion in GenBank, BEAST inputs and outputs, TempEst inputs and outputs and pipe-
line Perl scripts, are available from: doi://10.17635/lancaster/researchdata/111”.
This now appears in a Data Availability section in the PDF and HTML versions of the Article.
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